Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

IL-15 maintains T-cell survival via S-nitrosylation-mediated inhibition of caspase-3.

Saligrama PT, Fortner KA, Secinaro MA, Collins CC, Russell JQ, Budd RC.

Cell Death Differ. 2014 Jun;21(6):904-14. doi: 10.1038/cdd.2014.10. Epub 2014 Feb 7.

2.

The c-FLIPL cleavage product p43FLIP promotes activation of extracellular signal-regulated kinase (ERK), nuclear factor κB (NF-κB), and caspase-8 and T cell survival.

Koenig A, Buskiewicz IA, Fortner KA, Russell JQ, Asaoka T, He YW, Hakem R, Eriksson JE, Budd RC.

J Biol Chem. 2014 Jan 10;289(2):1183-91. doi: 10.1074/jbc.M113.506428. Epub 2013 Nov 25.

3.

Reduced immune response to Borrelia burgdorferi in the absence of γδ T cells.

Shi C, Sahay B, Russell JQ, Fortner KA, Hardin N, Sellati TJ, Budd RC.

Infect Immun. 2011 Oct;79(10):3940-6. doi: 10.1128/IAI.00148-11. Epub 2011 Jul 18.

4.

Activation of gamma delta T cells by Borrelia burgdorferi is indirect via a TLR- and caspase-dependent pathway.

Collins C, Shi C, Russell JQ, Fortner KA, Budd RC.

J Immunol. 2008 Aug 15;181(4):2392-8.

5.

Spatial differences in active caspase-8 defines its role in T-cell activation versus cell death.

Koenig A, Russell JQ, Rodgers WA, Budd RC.

Cell Death Differ. 2008 Nov;15(11):1701-11. doi: 10.1038/cdd.2008.100. Epub 2008 Jul 11.

6.

c-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival.

Hinshaw-Makepeace J, Huston G, Fortner KA, Russell JQ, Holoch D, Swain S, Budd RC.

Eur J Immunol. 2008 Jan;38(1):54-63.

7.

Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.

Misra RS, Russell JQ, Koenig A, Hinshaw-Makepeace JA, Wen R, Wang D, Huo H, Littman DR, Ferch U, Ruland J, Thome M, Budd RC.

J Biol Chem. 2007 Jul 6;282(27):19365-74. Epub 2007 Apr 26.

8.

Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

Wu W, Misra RS, Russell JQ, Flavell RA, Rincón M, Budd RC.

J Biol Chem. 2006 Apr 21;281(16):10682-90. Epub 2006 Feb 2.

9.

Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi.

Shi C, Wolfe J, Russell JQ, Fortner K, Hardin N, Anguita J, Budd RC.

Infect Immun. 2006 Feb;74(2):1156-60.

10.

Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8.

Dohrman A, Russell JQ, Cuenin S, Fortner K, Tschopp J, Budd RC.

J Immunol. 2005 Jul 1;175(1):311-8.

11.

Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation.

Dohrman A, Kataoka T, Cuenin S, Russell JQ, Tschopp J, Budd RC.

J Immunol. 2005 May 1;174(9):5270-8.

12.

Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates.

Misra RS, Jelley-Gibbs DM, Russell JQ, Huston G, Swain SL, Budd RC.

J Immunol. 2005 Apr 1;174(7):3999-4009.

13.

Cellular FLIP long form-transgenic mice manifest a Th2 cytokine bias and enhanced allergic airway inflammation.

Wu W, Rinaldi L, Fortner KA, Russell JQ, Tschopp J, Irvin C, Budd RC.

J Immunol. 2004 Apr 15;172(8):4724-32.

14.

Liver damage by infiltrating CD8+ T cells is Fas dependent.

Kennedy NJ, Russell JQ, Michail N, Budd RC.

J Immunol. 2001 Dec 1;167(11):6654-62.

15.

A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.

Mixter PF, Russell JQ, Morrissette GJ, Charland C, Aleman-Hoey D, Budd RC.

J Immunol. 1999 May 15;162(10):5747-56.

16.

Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens.

Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, Budd RC.

J Exp Med. 1998 Sep 21;188(6):1147-57.

17.

Anti-CD40L accelerates renal disease and adenopathy in MRL-lpr mice in parallel with decreased thymocyte apoptosis.

Russell JQ, Mooney T, Cohen PL, MacPherson B, Noelle RJ, Budd RC.

J Immunol. 1998 Jul 15;161(2):729-39.

18.

Down-modulation of CD2 delays deletion of superantigen-responsive T cells.

Fortner KA, Russell JQ, Budd RC.

Eur J Immunol. 1998 Jan;28(1):70-9.

19.

Transgene-encoded human CD2 acts in a dominant negative fashion to modify thymocyte selection signals in mice.

Melton E, Sarner N, Torkar M, van der Merwe PA, Russell JQ, Budd RC, Mamalaki C, Tolaini M, Kioussis D, Zamoyska R.

Eur J Immunol. 1996 Dec;26(12):2952-63.

PMID:
8977291
20.

Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.

Mixter PF, Russell JQ, Durie FH, Budd RC.

J Immunol. 1995 Mar 1;154(5):2063-74.

PMID:
7868883
21.

Delayed kinetics of T lymphocyte anergy and deletion in lpr mice.

Mixter PF, Russell JQ, Budd RC.

J Autoimmun. 1994 Dec;7(6):697-710.

PMID:
7534079
22.

Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors.

Roessner K, Fikrig E, Russell JQ, Cooper SM, Flavell RA, Budd RC.

Eur J Immunol. 1994 Feb;24(2):320-4.

PMID:
7905415
23.

Laboratory review of reference strains of Corynebacterium diphtheriae indicates mistyped intermedius strains.

Coyle MB, Nowowiejski DJ, Russell JQ, Groman NB.

J Clin Microbiol. 1993 Nov;31(11):3060-2.

24.

CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.

Landolfi MM, Van Houten N, Russell JQ, Scollay R, Parnes JR, Budd RC.

J Immunol. 1993 Jul 15;151(2):1086-96.

PMID:
7687614
25.

CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.

Budd RC, Russell JQ, van Houten N, Cooper SM, Yagita H, Wolfe J.

J Immunol. 1992 Feb 15;148(4):1055-64.

PMID:
1346621
26.

The molecular epidemiology of three biotypes of Corynebacterium diphtheriae in the Seattle outbreak, 1972-1982.

Coyle MB, Groman NB, Russell JQ, Harnisch JP, Rabin M, Holmes KK.

J Infect Dis. 1989 Apr;159(4):670-9.

PMID:
2494266
27.

Oral toxicity of ferric dimethyl-dithiocarbamate (ferbam) and tetramethylthiuram disulfide (thiram) in rodents.

Lee CC, Russell JQ, Minor JL.

J Toxicol Environ Health. 1978 Jan;4(1):93-106.

PMID:
633415
28.

Biliary excretion of cardiac glycosides.

Russell JQ, Klaassen CD.

J Pharmacol Exp Ther. 1973 Sep;186(3):455-62. No abstract available.

PMID:
4728329
29.

Species variation in the biliary excretion of ouabain.

Russell JQ, Klaassen CD.

J Pharmacol Exp Ther. 1972 Dec;183(3):513-9. No abstract available.

PMID:
4636390

Supplemental Content

Loading ...
Support Center